Results for tag: "Preeclampsia Laboratory Testing"

In the field of diagnostics, preeclampsia laboratory testing is an important niche that focuses on the detection and monitoring of preeclampsia, a pregnancy-related condition characterized by high blood pressure and often associated with signs of damage to other organ systems. Testing is critical as preeclampsia can lead to serious complications for both mother and child if it is not diagnosed and managed effectively. The market for these tests includes a range of diagnostic assays and biomarker tests, which can measure factors such as protein levels in the urine (proteinuria), liver enzymes, blood platelets, and the levels of certain angiogenic factors that can be indicative of the disorder. These tests not only help in the initial diagnosis but are also utilized for monitoring the progression of the condition throughout the pregnancy. As the disorder is relatively common and poses a major health risk, the market for preeclampsia testing is an integral part of prenatal care and maternal health services. Companies active in the preeclampsia laboratory testing market include PerkinElmer Inc., Thermo Fisher Scientific Inc., Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, and Abbott Laboratories. These companies offer a range of solutions from immunoassays to automated platforms that are used in clinical laboratories for the assessment and management of preeclampsia. Show Less Read more